Plain-English translation of NCT04434807 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
When someone has a sudden bleed in the brain (intracerebral hemorrhage), it's a medical emergency. This trial is testing whether using a special minimally invasive surgical tool called the Aurora surgiscope—which allows doctors to remove the blood clot through a tiny opening—helps patients recover better than standard medical care alone. The surgery would happen very early, within 8 hours of the bleeding starting.
Brain bleeds can cause serious disability or death, and doctors aren't sure if removing the blood clot quickly with minimally invasive surgery helps patients have better outcomes compared to treating them with medication alone. This trial will help answer that important question.
You likely qualify if…
You likely don't qualify if…
If you qualify and agree to join, you'll be randomly assigned to one of two groups: one group will receive the minimally invasive surgery followed by standard stroke care in a hospital unit, while the other group will receive standard medical care alone. After treatment, you'll be followed for 6 months with check-ups to see how well you're recovering. The study includes about 240 patients across multiple hospitals.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Australia